French Cardiac Surgeon Brings Father 10,000 km to Seoul for Rare Dual-Donor Liver Transplant
When Mohamed El Kettani, a 64-year-old Moroccan-born dual citizen of France and Morocco, was told that a liver transplant was virtually impossible in...
Search results for "K-Bio"
10 Reasons Grapes Are Good for You—Even If You Have Diabetes
A single grape may be small, but it packs a powerful nutritional punch. Rich in essential vitamins, minerals, and protective antioxidants, grapes...
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%
Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short
Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment
For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a...
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven
Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.
Medical AI Can Explain Its Decisions—but Can Clinicians Trust Its Reasons?
Artificial intelligence in medical imaging can analyze brain magnetic resonance imaging scans not only to estimate...
EZH1 Mutation 'Locks' Cancer-Fighting Genes to Fuel Thyroid Tumors, Study Finds
Cancer cells do not grow simply by switching on genes that drive proliferation; they can also lock away genes that keep...
Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market
Celltrion announced on the 24th that it has submitted a marketing authorization application to the European Medicines...
GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition
A new oral therapy is now available for patients with ROS1-positive lung cancer whose disease has progressed following...